Estadístiques de Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial
Visites totals
| views | |
|---|---|
| Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial | 58 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 3 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| perez-neo-tras.pdf | 36 |
| perez-neo-tras.pdf(legacy) | 22 |
Vistes principals per país
| views | |
|---|---|
| United States | 36 |
| Sweden | 8 |
| Spain | 5 |
| Belgium | 3 |
| Australia | 1 |
| Ireland | 1 |
| India | 1 |
| Mongolia | 1 |
| Malaysia | 1 |
| New Zealand | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ann Arbor | 7 |
| Boardman | 7 |
| San Ramon | 5 |
| Fairfield | 4 |
| Ashburn | 3 |
| Barcelona | 3 |
| Menlo Park | 3 |
| Alella | 1 |
| Alicante | 1 |
| Auckland | 1 |
| Cambridge | 1 |
| Cupertino | 1 |
| Dublin | 1 |
| Mountain View | 1 |
| Mumbai | 1 |
| Pinjarra | 1 |
| Sacramento | 1 |
| San Diego | 1 |
| Shah Alam | 1 |
| Sükhbaatar | 1 |